Engineering mRNA-Lipid nanoparticle (LNP) vaccines against multidrug resistant bacteria: current and future prospects.
This review highlights the significant potential of mRNA-lipid nanoparticle (LNP) technology for application in bacterial vaccines, with a long-term goal to provide critical tools in controlling problematic microbial infections regardless of their antimicrobial resistance (AMR) profile. The current landscape of bacteri...